Table 2.
Scenario 1 | Scenario 2 | ||
---|---|---|---|
Question of interest | Design a controller to keep the physiological variable within X% of a set-point | Is a controller stable under variable patient conditions | |
Context of use | The controller will be synthesized by optimizing parameters to the computational patient model | The computational patient model will be used to perform a risk-based evaluation of the controller performance before being used in clinical studies. | |
Model risk | Influence on decision | High – no other evidence will be used to support the decision | High – no other evidence will be used to support the decision |
Consequence of decision | Low – following design of the controller, a series of studies including additional computational testing and animal studies will be performed to evaluate the controller performance before being used on patients | High – use of the controller on patients could lead to injury | |
Overall risk | Medium | High | |
Example credibility factors | Qualitative: Parsimonious, low order, transparent, physiological relevant Quantitative: Linearizable, identifiable, predictive accuracy, reproduces uncertainty bounds | Qualitative: Transparent, physiologically relevant Quantitative: Identifiable, predictive accuracy, reproduces uncertainty bounds, generalizable | |
Credibility activities | Develop and perform plan to gather credibility evidence: experimental design, comparator (e.g., animal model), data analysis plan | ||
The two scenarios outline example model risk and credibility factors. The noted model risk components including influence on decision and consequence of decision are different here to highlight how use of a model may influence the necessary evidence to support that use.